Your browser doesn't support javascript.
loading
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B.
Garrison, Dominique A; Jin, Yan; Talebi, Zahra; Hu, Shuiying; Sparreboom, Alex; Baker, Sharyn D; Eisenmann, Eric D.
Afiliação
  • Garrison DA; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
  • Jin Y; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
  • Talebi Z; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
  • Hu S; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
  • Sparreboom A; Division of Outcomes and Translational Sciences, The Ohio State University, Columbus, OH 43210, USA.
  • Baker SD; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
  • Eisenmann ED; Division of Pharmaceutics and Pharmacology, The Ohio State University, Columbus, OH 43210, USA.
Molecules ; 27(20)2022 Oct 12.
Article em En | MEDLINE | ID: mdl-36296409

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Itraconazol Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Itraconazol Idioma: En Ano de publicação: 2022 Tipo de documento: Article